Related Experiment Video
Updated: Jul 19, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
COVID-19 Vaccination Status Among Korean Pediatric Population With Comorbidities
Areum Shin1, Dong Wook Kim2, Young-Eun Kim3
1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Insights
Korean children with comorbidities show higher COVID-19 vaccination rates, yet remain low overall. Immunocompromised children have the lowest two-dose rates, indicating a need for proactive vaccination strategies.
Area of Science:
- Pediatric Infectious Diseases
- Public Health
- Vaccinology
Background:
- Children with comorbidities are at increased risk for severe COVID-19.
- Low COVID-19 vaccination rates persist in Korean children, particularly those aged 5-11 years.
Purpose of the Study:
- To analyze COVID-19 vaccination status in Korean pediatric patients (5-17 years) with comorbidities.
- To identify disparities in vaccination rates based on comorbidity type and age group.
Main Methods:
- Utilized the National Health Insurance Service database for data extraction.
- Analyzed vaccination status for pediatric populations with and without comorbidities up to July 2022.
Main Results:
- Pediatric patients with comorbidities had higher vaccination rates than the general pediatric population across age groups (5-11 and 12-17 years).
- Significant variations in vaccination rates were observed among different comorbidity categories.
- Children with immunodeficiency exhibited the lowest two-dose vaccination rates (1.1% for 5-11 years, 51.2% for 12-17 years).
Conclusions:
- Despite higher rates among those with comorbidities, overall pediatric COVID-19 vaccination in Korea remains low and stagnant.
- Targeted, proactive vaccination strategies are essential, especially for high-risk groups like children with immunodeficiency.
- Continuous surveillance is crucial to monitor and improve pediatric vaccination coverage.
Abstract:
The pediatric population with comorbidities is a high-risk group for severe coronavirus disease 2019 (COVID-19). As of January 2023, the COVID-19 vaccination rate for at least two doses among Korean children 5-11 years is low at 1.1%. We summarized the COVID-19 vaccination status for the pediatric population (5-17 years) with comorbidities through July 2022 using the National Health Insurance Service database. Pediatric patients with comorbidities had higher vaccination rates than the general pediatric population (2.4% vs. 1.1% in 5-11-year-olds [P < 0.001], 76.5% vs. 66.1% in 12-17-year-olds [P < 0.001]). However, there were substantial differences according to comorbidity category, and the 2-dose vaccination rate was lowest among children with immunodeficiency in all age groups (1.1% in 5-11-year-olds, 51.2% in 12-17-year-olds). The COVID-19 vaccination rate among Korean children has remained stagnant at a low proportion despite ongoing outreach. Thus, more proactive strategies are needed alongside continuous surveillance.
More Related Videos
Related Concept Videos
Vaccinations
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Asthma-III: Symptoms and Complications
Classification of Asthma

